GENE ONLINE|News &
Opinion
Blog

Autoimmune Disease
Netherlands-based Argenx Raises $1.1 Billion in Global Offering Following Success in Clinical Trials
2023-07-23
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Vera Therapeutics Eyes Phase 3 For Kidney Disease Candidate Following Positive Data
2023-01-04
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Vallon and GRI Bio Strike a Merger Deal, Joining Forces for Innovative NKT Cell Regulators
2022-12-14
Japan Approves AstraZeneca’s Complement Inhibitor For Rare Muscle Disorder
2022-08-26
Takeda Announces Positive Topline From Pivotal Trial For Autoimmune Disease
2022-07-25
How Single Cell Sequencing is Advancing Biomedical Research
2022-07-15
New Mitochondrial Response Pathway May Advance Treatments for Inflammatory Diseases
2022-07-14
AbbVie & Cugene Join Forces to Tackle Autoimmune Diseases
2022-05-17
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
Sanofi’ Enjaymo Wins FDA Approval for Rare Autoimmune Anemia
2022-02-07
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
Mozart Therapeutics Makes Play with $55 Million Series A to Capitalize on Novel Tregs Pathway
2021-10-27
GentiBio Bags $157 Million in Series A to Fund Development of Treg Cell Therapies
2021-08-11
1 2
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top